Emami (531162) Q3 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 24/25 earnings summary
19 Jun, 2026Executive summary
Core domestic business grew 8.6% in Q3 FY25 with 6% volume growth, while consolidated Q3 revenue reached INR 1,049 crores, up 5% year-over-year; domestic core net sales rose 9% in Q3.
Profit after tax increased 8% in Q3 FY25 and 12% in 9MFY25, with margin expansion across gross, EBITDA, and PAT levels.
BoroPlus and healthcare segments delivered strong double-digit growth, with BoroPlus up 20% and healthcare up 13% in Q3, led by Zandu Care.
Rebranding of Fair and Handsome to Smart and Handsome aims to broaden the male grooming portfolio, with new campaigns and ambassador.
Board approved a second interim dividend of INR 4 per share (400%) for FY24; total interim dividends for 9MFY25 reached INR 8 per share (800%).
Financial highlights
Q3 FY25 consolidated revenue: INR 1,049 crores (+5% YoY); PAT: INR 279 crores (+8% YoY); EBITDA: INR 339 crores (+8% YoY); EPS: INR 6.39.
9MFY25 consolidated revenue: INR 2,846 crores (+6% YoY); PAT: INR 641 crores (+11% YoY); EBITDA: INR 806 crores (+9% YoY).
Gross margin expanded by 150 bps to 70.3% in Q3; EBITDA margin up 70 bps in Q3 and 80 bps in 9MFY25.
Operating cash flow for nine months estimated at INR 500-550 crores.
Dividend payout for FY24 totals 800% (INR 8 per share), with a payout of INR 349 crores for 9MFY25.
Outlook and guidance
Management expects continued double-digit growth in BoroPlus and healthcare in Q4, with positive momentum in core brands.
Plans to focus on new product development in male grooming and expand digital and ATL/BTL campaigns.
Weighted average price increase of 1.5%-2% expected in the coming quarter.
Tax rate projected at 8%-9% for FY25 and around 10% for FY26.
Assam facility continues to benefit from income tax incentives until FY 2025-26.
Latest events from Emami
- Q1 FY25 saw 10% revenue and 11% profit growth, with margin gains and strong summer-led sales.531162
Q1 24/2519 Jun 2026 - Q2 profit and margin rose, interim dividend declared, and core brands led growth.531162
Q2 24/2519 Jun 2026 - FY26 saw lower revenue and profit, but D2C and new-age brands showed strong growth.531162
Q4 25/2621 May 2026 - Double-digit sales and profit growth, margin gains, and interim dividend highlight strong Q3 FY26.531162
Q3 25/2613 Apr 2026 - Flat revenue, higher margins, and strong pain management offset summer category declines.531162
Q1 25/263 Feb 2026 - FY25 delivered 6.5% revenue and 11% PAT growth, with strong brands and a special dividend.531162
Q4 24/2521 Nov 2025 - Q2 FY26 revenue fell 10% and profit dropped 29.7%, with a Rs. 4 interim dividend declared.531162
Q2 25/2610 Nov 2025